This transcript provides a detailed pathology discussion examining the features of a Spindle Cell Hemangioma (formerly Spindle Cell Hemangioendothelioma), a benign but often histologically and clinically alarming vascular lesion usually presenting as a subcutaneous nodule.
The tumor exhibits a characteristic biphasic pattern: dilated, cavernous vascular spaces alongside solid, cellular areas composed of bland spindle cells and epithelioid cells. The cellularity, combined with rich blood content, can mimic malignancy, particularly Kaposi Sarcoma (KS), requiring confirmation via negative HHV8 staining. Clinically, the tumor can be multifocal and grow into the lumen of adjacent veins, raising concern for metastasis, although long-term follow-up confirms its benign course. A key diagnostic challenge noted is that CD34 vascular marker is often negative in large parts of the lesion. Spindle Cell Hemangiomas are frequently associated with IDH1 or IDH2 mutations and the Maffucci Syndrome.
Spindle Cell Hemangioma: Histopathology and Clinical Significance
0:09 Characteristic Morphology: The lesion presents as a multi-nodular subcutaneous proliferation characterized by dilated, cavernous blood spaces with thin walls, often containing blood and serum.
1:10 Biphasic Appearance: In addition to the cavernous areas, the tumor includes cellular areas composed of spindle cells and plump, epithelial-looking cells, which contribute to a "scary" or busy appearance, potentially leading to misdiagnosis.
1:48 Differential Diagnosis (Kaposi Sarcoma): The appearance can resemble malignancy, specifically Kaposi Sarcoma (KS). The speaker notes that KS is typically dermal-centered, while Spindle Cell Hemangioma is usually a solitary subcutaneous nodule. HHV8 staining should be negative here, definitively ruling out KS.
3:30 Histologic Detail: The tumor is usually a multinodular subcutaneous mass with a biphasic pattern. Even in the cellular (solid-appearing) epithelioid areas, immunohistochemistry (IHC) with markers like CD31 or ERG will demonstrate that these are packed, well-formed vessels.
5:31 CD34 Pitfall: A unique feature of this entity is that CD34 is often negative in significant portions of the lesion, despite its vascular nature. This makes CD34 an unreliable marker for identifying these tumors.
6:28 Benign, but Alarmingly Multifocal: Although benign, Spindle Cell Hemangiomas tend to be multifocal (multiple nodules in the same extremity) and may arise out of, or extend into, the lumen of a pre-existing vein.
7:08 History and Nomenclature: Due to its frightening clinical presentation (multifocality and intravascular growth), the lesion was initially named Spindle Cell Hemangioendothelioma (implying intermediate malignancy risk) in the 1980s. It was later renamed Spindle Cell Hemangioma after long-term follow-up confirmed its benign course.
8:31 Syndromic Association: The lesion is associated with Maffucci syndrome (IDH1/IDH2 germline mutations, multiple enchondromas of bone, and increased risk of chondrosarcoma). Association with Klippel-Trenaunay syndrome is also reported.
9:15 Molecular Testing: Both sporadic and syndromic cases often carry IDH1 or IDH2 mutations, which can be used for molecular confirmation if the pathology is ambiguous.
9:39 IHC Limitation: The standard IDH1 immunostain used for brain tumors (gliomas) is typically not effective for identifying the IDH mutations present in Spindle Cell Hemangioma.